$3.54
-0.055-1.53%
Last update: Nov 2, 11:58 AM

Wave Life Sciences (WVE) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.33 | $-0.30 | $-0.32 | $-0.27 |
| Actual | $-0.30 | $-0.34 | $-0.13 | $-0.30 |
| Surprise | +9.09% | -13.3% | +59.4% | -11.1% |
| Revenue | ||||
| Estimate | $4.1M | $7.4M | $8.5M | $14.2M |
| Actual | $13.2M | $2.3M | $38.2M | $17.2M |
| Surprise | +220.2% | -69.3% | +350.7% | +21.6% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $-0.33 | $-0.34 | $-0.32 |
| Revenue | |||
| Consensus | $6.9M | $8.2M | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 27, 2026 | $-0.30 | $-0.33 | 9.09 % |
| Q2 | Jul 30, 2026 | $-0.34 | $-0.30 | -13.3 % |
| Q1 | Apr 28, 2026 | $-0.13 | $-0.32 | 59.4 % |
| Q4 | Feb 26, 2026 | $-0.30 | $-0.27 | -11.1 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 27, 2026 | $13.16M | $4.11M | 220.2 % |
| Q2 | Jul 30, 2026 | $2.27M | $7.40M | -69.3 % |
| Q1 | Apr 28, 2026 | $38.25M | $8.49M | 350.7 % |
| Q4 | Feb 26, 2026 | $17.24M | $14.18M | 21.6 % |